首页 > 最新文献

Circulation最新文献

英文 中文
Bradycardia in Athletes: New Insights. 运动员的心动过缓:新的见解。
IF 38.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-03 Epub Date: 2026-03-02 DOI: 10.1161/CIRCULATIONAHA.125.078643
Tracy Baynard, Sushant M Ranadive
{"title":"Bradycardia in Athletes: New Insights.","authors":"Tracy Baynard, Sushant M Ranadive","doi":"10.1161/CIRCULATIONAHA.125.078643","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.125.078643","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"153 9","pages":"631-633"},"PeriodicalIF":38.6,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147343874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction. 修正:选择性mRNA翻译:心肌梗死后心肌下垂的新参与者。
IF 38.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-03 Epub Date: 2026-03-02 DOI: 10.1161/CIR.0000000000001425
Jinlong He, Yi Zhu
{"title":"Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.","authors":"Jinlong He, Yi Zhu","doi":"10.1161/CIR.0000000000001425","DOIUrl":"https://doi.org/10.1161/CIR.0000000000001425","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"153 9","pages":"e909"},"PeriodicalIF":38.6,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147343824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. 2026心脏病和中风统计:来自美国心脏协会的美国和全球数据报告
IF 38.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-03 Epub Date: 2026-01-21 DOI: 10.1161/CIR.0000000000001412
Latha P Palaniappan, Norrina B Allen, Zaid I Almarzooq, Cheryl A M Anderson, Pankaj Arora, Christy L Avery, Carissa M Baker-Smith, Nisha Bansal, Maria E Currie, Rebecca S Earlie, Wenjun Fan, Jessica L Fetterman, Bethany Barone Gibbs, Debra G Heard, Swapnil Hiremath, Haoyun Hong, Hyacinth I Hyacinth, Chinwe Ibeh, Tian Jiang, Michelle C Johansen, Dhruv S Kazi, Darae Ko, Tak W Kwan, Michelle H Leppert, Yilun Li, Jared W Magnani, Karlyn A Martin, Seth S Martin, Erin D Michos, Michael E Mussolino, Oluwabunmi Ogungbe, Nisha I Parikh, Marco V Perez, Sarah M Perman, Ashish Sarraju, Nilay S Shah, Mellanie V Springer, Marie-Pierre St-Onge, Evan L Thacker, Seda Tierney, Sarah M Urbut, Harriette G C Van Spall, Jenifer H Voeks, Seamus P Whelton, Sally S Wong, Juan Zhao, Sadiya S Khan

Background: The American Heart Association annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and cardiovascular-kidney-metabolic syndrome) that contribute to cardiovascular health. The 2026 Heart Disease and Stroke Statistics Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).

Methods: The American Heart Association, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistics Update with review of published literature through the year before writing. The 2026 Statistics Update is the product of a full year's worth of effort in 2025 by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year's edition includes a new chapter on cardiovascular-kidney-metabolic syndrome, as well as an expanded chapter on tobacco and nicotine use and exposure.

Results: Each of the chapters in the Statistics Update focuses on a different topic related to heart disease and stroke statistics.

Conclusions: The Statistics Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

背景:美国心脏协会每年报告与心脏病、中风和心血管危险因素相关的最新统计数据,包括核心健康行为(吸烟、体育活动、营养、睡眠和肥胖)和健康因素(胆固醇、血压、血糖控制和心血管-肾-代谢综合征),这些因素有助于心血管健康。《2026年心脏病和中风统计更新》提供了一系列主要临床心脏和循环系统疾病的最新数据(包括中风、脑部健康、妊娠并发症、肾脏疾病、先天性心脏病、心律失常、心脏骤停、亚临床动脉粥样硬化、冠心病、心肌病、心力衰竭、瓣膜疾病、静脉血栓栓塞、心血管疾病和心血管疾病)。(以及外周动脉疾病)和相关结果(包括护理质量、程序和经济成本)。方法:美国心脏协会通过其流行病学和预防统计委员会持续监测和评估美国和全球心脏病和中风的数据来源,在年度统计更新中提供最新信息,并在撰写前一年审查已发表的文献。《2026年统计更新》是2025年由敬业的志愿临床医生和科学家、忠诚的政府专业人员和美国心脏协会工作人员一整年努力的结果。今年的版本包括一个关于心血管肾脏代谢综合征的新章节,以及一个关于烟草和尼古丁使用和暴露的扩展章节。结果:统计更新中的每一章都侧重于与心脏病和中风统计相关的不同主题。结论:《最新统计数据》为普通公众、政策制定者、媒体专业人员、临床医生、卫生保健管理人员、研究人员、卫生倡导者和其他寻求有关这些因素和条件的最佳可用数据的人员提供了重要资源。
{"title":"2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.","authors":"Latha P Palaniappan, Norrina B Allen, Zaid I Almarzooq, Cheryl A M Anderson, Pankaj Arora, Christy L Avery, Carissa M Baker-Smith, Nisha Bansal, Maria E Currie, Rebecca S Earlie, Wenjun Fan, Jessica L Fetterman, Bethany Barone Gibbs, Debra G Heard, Swapnil Hiremath, Haoyun Hong, Hyacinth I Hyacinth, Chinwe Ibeh, Tian Jiang, Michelle C Johansen, Dhruv S Kazi, Darae Ko, Tak W Kwan, Michelle H Leppert, Yilun Li, Jared W Magnani, Karlyn A Martin, Seth S Martin, Erin D Michos, Michael E Mussolino, Oluwabunmi Ogungbe, Nisha I Parikh, Marco V Perez, Sarah M Perman, Ashish Sarraju, Nilay S Shah, Mellanie V Springer, Marie-Pierre St-Onge, Evan L Thacker, Seda Tierney, Sarah M Urbut, Harriette G C Van Spall, Jenifer H Voeks, Seamus P Whelton, Sally S Wong, Juan Zhao, Sadiya S Khan","doi":"10.1161/CIR.0000000000001412","DOIUrl":"10.1161/CIR.0000000000001412","url":null,"abstract":"<p><strong>Background: </strong>The American Heart Association annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and cardiovascular-kidney-metabolic syndrome) that contribute to cardiovascular health. The 2026 Heart Disease and Stroke Statistics Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs).</p><p><strong>Methods: </strong>The American Heart Association, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistics Update with review of published literature through the year before writing. The 2026 Statistics Update is the product of a full year's worth of effort in 2025 by dedicated volunteer clinicians and scientists, committed government professionals, and American Heart Association staff members. This year's edition includes a new chapter on cardiovascular-kidney-metabolic syndrome, as well as an expanded chapter on tobacco and nicotine use and exposure.</p><p><strong>Results: </strong>Each of the chapters in the Statistics Update focuses on a different topic related to heart disease and stroke statistics.</p><p><strong>Conclusions: </strong>The Statistics Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":"e275-e906"},"PeriodicalIF":38.6,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146008974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic and Iliac Calcifications as Predictors of Aortic Dissection, Aneurysm Rupture, and Peripheral Vascular Disease: A Prospective Cohort Study from the DANCAVAS Trials. 主动脉和髂骨钙化作为主动脉夹层、动脉瘤破裂和周围血管疾病的预测因子:来自DANCAVAS试验的前瞻性队列研究
IF 38.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/CIRCULATIONAHA.125.076240
Cecilie Skov Petersen, Zuzanna Karon, Lasse M Obel, Selma Hasific, Anna Mejldal, Lytfi Krasniqi, Mie Schæffer, Flemming H Steffensen, Lars Frost, Jess Lambrechtsen, Martin Busk, Grazina Urbonaviciene, Kenneth Egstrup, Marek Karon, Lars M Rasmussen, Jes S Lindholt, Axel C P Diederichsen

Background: There is limited evidence of the relationship between aortic and iliac calcification and aortic events (aortic dissection or aneurysm rupture) and major adverse limb events (MALEs; peripheral revascularization and lower limb amputation). The aim of this population-based prospective cohort study was to investigate the association of aortic and iliac calcifications with aortic events and MALEs.

Methods: All participants from the DANCAVAS (Danish Cardiovascular Screening) trials who received a full thoracoabdominal aortic computed tomography scan with recorded measurements of aortic and iliac calcification were included. The aorta and iliac artery calcifications were measured in a 5-segment model and categorized into quartiles, apart from the ascending aorta, which was categorized into 4 exposure groups, as the majority of participants had no calcification in the ascending aorta. The participants were followed from inclusion in the DANCAVAS trial until aortic events, MALE, death, or end of follow-up on May 1, 2025. We used a competing risk hazard regression model adjusted for demographics, cardiovascular risk factors, aortic diameter, and ankle-brachial index.

Results: In total, 13 065 participants were included in this study (94% men; mean age, 67±4 years). Participants were followed for a mean of 8 years, during which 42 experienced an aortic event, and 311 experienced a MALE. The analyses of the aortic event outcome showed significantly increased subdistribution hazard rates (SHRs) when having calcification scores in the fourth group or quartile for the ascending and abdominal aorta (SHR, 3.06 [95% CI, 1.15-8.16]; SHR, 7.61 [95% CI, 1.44-40.22], respectively). Calcification scores in the fourth group or quartile were strongly associated with MALEs in all segments: ascending aorta (SHR, 2.20 (95% CI, 1.56-3.10]), aortic arch (SHR, 6.49 [95% CI, 3.10-13.56]), descending aorta (SHR, 2.43; [95% CI, 1.45-4.08]), abdominal aorta (SHR, 7.89 [2.95-21.15]), and iliac arteries (SHR, 13.52 [95% CI, 4.32-42.24]).

Conclusion: Severe aortic and iliac calcification was associated with significantly higher risk of aortic events and MALEs, suggesting that quantifying aortic calcification may provide valuable prognostic information and potentially improve the risk stratification in patients with aortic aneurysm or peripheral artery disease.

背景:关于主动脉和髂骨钙化与主动脉事件(主动脉夹层或动脉瘤破裂)和主要肢体不良事件(男性、外周血运重建术和下肢截肢)之间关系的证据有限。这项基于人群的前瞻性队列研究的目的是调查主动脉和髂钙化与主动脉事件和男性的关系。方法:所有来自DANCAVAS(丹麦心血管筛查)试验的参与者均接受了胸腹主动脉计算机断层扫描,并记录了主动脉和髂动脉钙化的测量结果。主动脉和髂动脉的钙化在一个5段模型中被测量,并分为四分位数,除了升主动脉被分为4个暴露组,因为大多数参与者在升主动脉没有钙化。参与者从纳入DANCAVAS试验开始随访,直到2025年5月1日主动脉事件、男性、死亡或随访结束。我们使用了一个竞争风险回归模型,调整了人口统计学、心血管危险因素、主动脉直径和踝肱指数。结果:本研究共纳入13065名受试者(94%为男性,平均年龄67±4岁)。参与者平均随访8年,其中42人经历主动脉事件,311人经历男性心脏病。主动脉事件结局分析显示,当升主动脉和腹主动脉的钙化评分在第四组或四分位数时,亚分布危险率(SHRs)显著增加(SHR, 3.06 [95% CI, 1.15-8.16]; SHR, 7.61 [95% CI, 1.44-40.22])。第四组或四分位数的钙化评分与男性在所有节段的相关性很强:升主动脉(SHR, 2.20 (95% CI, 1.56-3.10))、主动脉弓(SHR, 6.49 [95% CI, 3.10-13.56])、降主动脉(SHR, 2.43; [95% CI, 1.45-4.08])、腹主动脉(SHR, 7.89[2.95-21.15])和髂动脉(SHR, 13.52 [95% CI, 4.32-42.24])。结论:严重的主动脉和髂骨钙化与主动脉事件和男性的风险显著升高相关,表明量化主动脉钙化可能提供有价值的预后信息,并可能改善主动脉瘤或外周动脉疾病患者的风险分层。
{"title":"Aortic and Iliac Calcifications as Predictors of Aortic Dissection, Aneurysm Rupture, and Peripheral Vascular Disease: A Prospective Cohort Study from the DANCAVAS Trials.","authors":"Cecilie Skov Petersen, Zuzanna Karon, Lasse M Obel, Selma Hasific, Anna Mejldal, Lytfi Krasniqi, Mie Schæffer, Flemming H Steffensen, Lars Frost, Jess Lambrechtsen, Martin Busk, Grazina Urbonaviciene, Kenneth Egstrup, Marek Karon, Lars M Rasmussen, Jes S Lindholt, Axel C P Diederichsen","doi":"10.1161/CIRCULATIONAHA.125.076240","DOIUrl":"https://doi.org/10.1161/CIRCULATIONAHA.125.076240","url":null,"abstract":"<p><strong>Background: </strong>There is limited evidence of the relationship between aortic and iliac calcification and aortic events (aortic dissection or aneurysm rupture) and major adverse limb events (MALEs; peripheral revascularization and lower limb amputation). The aim of this population-based prospective cohort study was to investigate the association of aortic and iliac calcifications with aortic events and MALEs.</p><p><strong>Methods: </strong>All participants from the DANCAVAS (Danish Cardiovascular Screening) trials who received a full thoracoabdominal aortic computed tomography scan with recorded measurements of aortic and iliac calcification were included. The aorta and iliac artery calcifications were measured in a 5-segment model and categorized into quartiles, apart from the ascending aorta, which was categorized into 4 exposure groups, as the majority of participants had no calcification in the ascending aorta. The participants were followed from inclusion in the DANCAVAS trial until aortic events, MALE, death, or end of follow-up on May 1, 2025. We used a competing risk hazard regression model adjusted for demographics, cardiovascular risk factors, aortic diameter, and ankle-brachial index.</p><p><strong>Results: </strong>In total, 13 065 participants were included in this study (94% men; mean age, 67±4 years). Participants were followed for a mean of 8 years, during which 42 experienced an aortic event, and 311 experienced a MALE. The analyses of the aortic event outcome showed significantly increased subdistribution hazard rates (SHRs) when having calcification scores in the fourth group or quartile for the ascending and abdominal aorta (SHR, 3.06 [95% CI, 1.15-8.16]; SHR, 7.61 [95% CI, 1.44-40.22], respectively). Calcification scores in the fourth group or quartile were strongly associated with MALEs in all segments: ascending aorta (SHR, 2.20 (95% CI, 1.56-3.10]), aortic arch (SHR, 6.49 [95% CI, 3.10-13.56]), descending aorta (SHR, 2.43; [95% CI, 1.45-4.08]), abdominal aorta (SHR, 7.89 [2.95-21.15]), and iliac arteries (SHR, 13.52 [95% CI, 4.32-42.24]).</p><p><strong>Conclusion: </strong>Severe aortic and iliac calcification was associated with significantly higher risk of aortic events and MALEs, suggesting that quantifying aortic calcification may provide valuable prognostic information and potentially improve the risk stratification in patients with aortic aneurysm or peripheral artery disease.</p>","PeriodicalId":10331,"journal":{"name":"Circulation","volume":" ","pages":""},"PeriodicalIF":38.6,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147324804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response by de Veld et al to Letter Regarding Article, "Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial". de Veld等人对《长期随访中经静脉与皮下除颤器治疗的器械相关并发症:PRAETORIAN-XL试验》一文的回应。
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/circulationaha.125.078380
Jolien A de Veld,Reinoud E Knops,Louise R A Olde Nordkamp
{"title":"Response by de Veld et al to Letter Regarding Article, \"Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial\".","authors":"Jolien A de Veld,Reinoud E Knops,Louise R A Olde Nordkamp","doi":"10.1161/circulationaha.125.078380","DOIUrl":"https://doi.org/10.1161/circulationaha.125.078380","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"99 1","pages":"e267-e268"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter by Shi and Zeng Regarding Article, "Partnership Model of Regionalized Care for Congenital Heart Disease in Resource-Limited Settings: Results From the ASSIST Project". 施、曾关于“资源有限条件下先天性心脏病区域护理伙伴关系模式:来自ASSIST项目的结果”一文的信函。
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/circulationaha.125.077135
Jiayue Shi,Xuefan Zeng
{"title":"Letter by Shi and Zeng Regarding Article, \"Partnership Model of Regionalized Care for Congenital Heart Disease in Resource-Limited Settings: Results From the ASSIST Project\".","authors":"Jiayue Shi,Xuefan Zeng","doi":"10.1161/circulationaha.125.077135","DOIUrl":"https://doi.org/10.1161/circulationaha.125.077135","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"296 1","pages":"e272"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Abstract Sun602: Lower Survival After Out-of- Hospital Cardiac Arrest in Older Females: The Joint Effect of Age and Sex. 摘要Sun602:老年女性院外心脏骤停后生存率较低:年龄和性别的共同影响。
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/cir.0000000000001421
Emad Awad,Brian Grunau,Jim Christenson,Lamis Alamoudi,Karen Humphries,Jennie Helmer
{"title":"Correction to: Abstract Sun602: Lower Survival After Out-of- Hospital Cardiac Arrest in Older Females: The Joint Effect of Age and Sex.","authors":"Emad Awad,Brian Grunau,Jim Christenson,Lamis Alamoudi,Karen Humphries,Jennie Helmer","doi":"10.1161/cir.0000000000001421","DOIUrl":"https://doi.org/10.1161/cir.0000000000001421","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"41 1","pages":"e907"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter by Zhao Regarding Article, "Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial". 关于文章“经静脉与皮下除颤器治疗在长期随访期间的器械相关并发症:PRAETORIAN-XL试验”Zhao的来信。
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/circulationaha.125.076701
Yun-Tao Zhao
{"title":"Letter by Zhao Regarding Article, \"Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial\".","authors":"Yun-Tao Zhao","doi":"10.1161/circulationaha.125.076701","DOIUrl":"https://doi.org/10.1161/circulationaha.125.076701","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"13 1","pages":"e265-e266"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response by Shi and Chen to Letter Regarding Article, "Partnership Model of Regionalized Care for Congenital Heart Disease in Resource-Limited Settings: Results From the ASSIST Project". 施、陈对文章“资源有限条件下先天性心脏病区化护理伙伴关系模式:来自ASSIST项目的结果”的回复
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/circulationaha.125.078381
Guocheng Shi,Huiwen Chen
{"title":"Response by Shi and Chen to Letter Regarding Article, \"Partnership Model of Regionalized Care for Congenital Heart Disease in Resource-Limited Settings: Results From the ASSIST Project\".","authors":"Guocheng Shi,Huiwen Chen","doi":"10.1161/circulationaha.125.078381","DOIUrl":"https://doi.org/10.1161/circulationaha.125.078381","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"28 1","pages":"e273-e274"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention. 微塑料和纳米塑料:心血管预防的新视角。
IF 37.8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2026-03-02 DOI: 10.1161/circulationaha.125.077882
Kai-Uwe Jarr,Annette Peters,Nicholas J Leeper
{"title":"Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.","authors":"Kai-Uwe Jarr,Annette Peters,Nicholas J Leeper","doi":"10.1161/circulationaha.125.077882","DOIUrl":"https://doi.org/10.1161/circulationaha.125.077882","url":null,"abstract":"","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"19 1","pages":"613-615"},"PeriodicalIF":37.8,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147329315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1